Abstract Objective To investigate the clinical features in children with tuberous sclerosis complex (TSC)-associated cardiac rhabdomyomas (CRM). Methods The clinical data of 15 children with TSC complicated by CRM were collected. The clinical features of the patients were analyzed, and TSC gene mutations were detected. Results Eleven cases (73%) developed multiple CRM. The majority of the tumors were located in the left and right ventricles. Most tumors presented as a round-like hyperechogenic mass with a clear margin on echocardiography. Arrhythmias occurred in 3 patients and 2 patients experienced heart failure. Gene mutation tests were performed in 2 patients, and pathogenic mutations were detected in both patients, which were TSC1 mutation and TSC2 mutation, respectively. Three patients were followed up for 6 to 38 months, and their CRM shrank or regressed spontaneously. Conclusions TSC-associated CRM is generally multiple. Heart failure and arrhythmias may occur in some patients. Echocardiography is important for diagnosis of CRM. TSC-associated CRM has an inclination to spontaneous regression. TSC can be diagnosed at a molecular genetic level by TSC gene mutation detection.
Hope N, Darcy AK. Tuberous sclerosis complex diagnostic criteria update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference[J]. Pediatr Neurol, 2013, 49(4): 243-254.
[2]
van Slegtenhorst M, de Hoogt R, Hermans C, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34[J]. Science, 1997, 277(8): 805-808.
[3]
The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16[J]. Cell, 1993, 75(7): 1305-1315.
[4]
Etuwewe B, John CM, Abdelaziz M. Asymptomatic cardiac rhabdomyoma in neonates: is surgery indicated?[J]. Images Paediatr Cardiol, 2009, 11(2): 1-8.
[5]
Padalino MA, Reffo E, Cerutti A, et al. Medical and surgical management of primary cardiac tumours in infants and children[J]. Cardiol Young, 2014, 24(2): 268-274.
Jozwiak S, Kotulska K, Kasprzyk-Obara J, et al. Clinical and genotype studies of cardiac tumors in 154 patients with tuberous sclerosis complex[J]. Pediatrics, 2006, 118(4): 1146-1151.
[11]
Kocabas A, Ekici F, Cetin II, et al. Cardiac rhabdomyomas associated with tuberous sclerosis complex in 11 children: presentation to outcome[J]. Pediatr Hematol Oncol, 2013, 30(2): 7l-79.
[12]
Yates JR, Maclean C, Higgins JN, et al. The Tuberous Sclerosis 2000 Study: presentation, initial assessments and implications for diagnosis and management[J]. Arch Dis Child, 2011, 96(11): 1020-1025.
[13]
Sciacca P, Giacchi V, Mattia C, et al. Rhabdomyomas and tuberous sclerosis complex: our experience in 33 cases[J]. BMC Cardiovasc Disord, 2014, 14: 66.
[14]
Atalay S, Aypar E, Ucar T, et al. Fetal and neonatal cardiac rhabdomyomas: clinical presentation, outcome and association with tuberous sclerosis complex[J]. Turk J Pediatr, 2010, 52(5): 481-487.
Hishitani T, Hoshino K, Ogawa K, et al. Rapid enlargement of cardiac rhabdomyoma during corticotropin therapy for infantile spasms[J]. Can J Cardiol, 1997, 13(1): 72-74.
[17]
Fu C, Ess KC. Conditional and domain-specific inactivation of the Tsc2 gene in neural progenitor cells[J]. Genesis, 2013, 51(4): 284-292.
[18]
Oyazato Y, Iijima K, Emi M, et al. Molecular analysis of TSC2/PKD1 contiguous gene deletion syndrome[J]. Kobe J Med Sci, 2011, 57(1): E1-E10.
